Enhancing Management of Chronic Pain and Symptoms Among Women Treated for Breast Cancer (Lymph-Flow)
NCT02462226 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2017-04-20
Summary
The purpose of this research study is to conduct a randomized clinical trial to evaluate the efficacy of the web-based The-Optimal-Lymph-Flow ™ system for managing chronic pain and symptoms related to lymphedema focusing on primary outcomes of pain reduction, secondary outcomes of symptom relief, limb volume difference by infra-red perometer, body mass index, quality of life related to pain.
Recruitment includes 120 patients who will be randomized according to pain/aching/soreness, and tenderness. Participants in the intervention group will be provided the web-based The-Optimal-Lymph-Flow ™ intervention and encourage to access and learn about the program during the 1-4 weeks of the study. Participants in the control group will receive the web-based arm precaution program. All the participants will have monthly online assessment of pain and symptoms at 4 and 8 weeks post-intervention as well as two in-person research visits, that is, prior to intervention and 12 weeks post-intervention.
Conditions
- Breast Cancer
- Pain
- Lymphedema
Interventions
- BEHAVIORAL
-
The-Optimal-Lymph-Flow
The-Optimal-Lymph-Flow ™ is a web-based educational and behavioral program focusing on self-care strategies to manage pain and symptoms related to lymphedema. The Optimal Lymph-Flow™ is the only evidence-based self-care program designed to effectively help women treated for breast cancer manage daily pain and symptoms related to lymphedema. Grounded in research-driven behavioral strategies, the program is premised on empowering, rather than inhibiting, how breast cancer survivors live their lives. It emphasizes "what to do," rather than "what to avoid." It features a safe, feasible and easily-integrated-into-daily-routine of exercises to promote lymph flow and drainage, as well as guidance to maintain an optimal BMI.
- BEHAVIORAL
-
Arm Precaution
The webpage also has a section entitled "Arm Precautions," representing current patient education that emphasizes precautionary lifestyle behaviors, such as avoidance of repetitive limb movement, lifting weighted objects, needle punctures, blood draw, and the use of compression garments for air travel in the affected limb.
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 89 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-01
- Primary Completion
- 2016-12-01
- Completion
- 2016-12-01
Countries
- United States
Study Locations
More Related Trials
-
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
NCT00376597 ·Status: COMPLETED
-
Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery
NCT02073045 ·Status: TERMINATED ·Phase: NA
-
Pilot Usability and Feasibility Testing on Kinect-Enhanced Training System for Lymphatic Exercises
NCT03999177 ·Status: COMPLETED ·Phase: NA
-
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
NCT06297265 ·Status: RECRUITING ·Phase: NA
-
Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management
NCT02992782 ·Status: COMPLETED ·Phase: NA
-
Treatment of Breast Cancer Related Lymphedema With Cell-assisted Lipotransfer
NCT02592213 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Breaststroke Swimming After Breast Cancer Treatment/Surgery as a Means of Treatment for Seroma, Lymphedema, and Chronic Arm and Chest Pain
NCT04080934 ·Status: RECRUITING ·Phase: NA
-
Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation
NCT01157767 ·Status: COMPLETED
-
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
NCT00383500 ·Status: COMPLETED ·Phase: NA
-
Predictors of Lymphedema Following Breast Cancer Surgery
NCT00202046 ·Status: COMPLETED
-
Body Awareness and Functionality in Lymphedema
NCT06036173 ·Status: COMPLETED
-
The Validity and Reliability of Self Measurement of Upper Limb Volume
NCT01225783 ·Status: UNKNOWN ·Phase: NA
-
Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema
NCT04690439 ·Status: RECRUITING ·Phase: NA
-
Lymphedema Prevention in Breast Cancer
NCT04112966 ·Status: COMPLETED ·Phase: NA
-
Complete Decongestive Therapy in Breast Cancer-Related Lymphedema
NCT02458391 ·Status: WITHDRAWN ·Phase: NA
-
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
NCT01276054 ·Status: TERMINATED ·Phase: PHASE2
-
Multi-Parametric Assessment of Breast Lymphedema
NCT02724514 ·Status: COMPLETED
-
PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema
NCT05056207 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Intervention
NCT05326165 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Night-time Compression Systems for Breast Cancer Related Lymphedema
NCT01550250 ·Status: COMPLETED ·Phase: NA
-
Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer Subjects
NCT02187289 ·Status: COMPLETED ·Phase: NA
-
Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema
NCT00679185 ·Status: COMPLETED ·Phase: NA
-
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
NCT01521000 ·Status: UNKNOWN ·Phase: NA
-
Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer
NCT03648983 ·Status: TERMINATED ·Phase: NA
-
Healthy ME: Advancing Health Equity in Lymphatic Pain and Lymphedema in Black and Hispanic Women With Breast Cancer
NCT06133959 ·Status: NOT_YET_RECRUITING ·Phase: NA